Biotech, Food & Drug

HB Ad Slot
HB Mobile Ad Slot

In today’s hyper-aware environment, concerns about food and drug safety are paramount for both companies and consumers.  The Food and Drug Administration (FDA) and the US Department of Agriculture (USDA) regulates the areas of biotech, food, and drug law. Additionally, laws including the 21st Century Cures Act, and cGMP (Current Good Manufacturing Processes), regulate industry standards/norms in food, cosmetics, and other industry-sectors. Visitors to the National Law Review will find the latest analysis of news, legislation, and upcoming cases/litigation as it relates to this area of law.

With researchers searching for new energy solutions and other developments in biotech, visitors to the NLR will have the opportunity to read content surrounding biosimilars, natural fuel production, medical devices, biotechnology, nanotechnology and materials, and the pharmaceuticals industry. Additionally, content relating to food and drug laws, limits on chemical use in cosmetic products, and other general health/safety topics are covered by the National Law Review and are updated regularly. Additionally, food safety and imports to the United States are also discussed as they become relevant. 

In addition to general health, science, and food/drug, the industry is also closely related to many of the issues related to intellectual property law. New applications for patents, intellectual property, licensing laws, and other areas which are governed by the PTAB court, often crossover into the industry.

New developments in legislation, including the legalization of recreational marijuana has created a new area ripe for legal analysis.  Regulations on how recreational marijuana can be advertised and marketed, distributed and the kind of insurance coverage necessary for dispensaries.  Additionally, employer drug-testing and marijuana statutes have been a hot area of litigation covered by the National Law Review.  

General practices in marketing standards, compliance of federal and state laws/legislation, licensing collaborations, and news related to bringing new products to the market, in the US and abroad, are among the areas visitors to NLR will read about daily. Drug pricing, changes in production standards, regulatory compliance, food safety and handling, drug laws (legalization of marijuana, both recreational and medicinal in the workplace), and labeling and nutritional requirements, are among the many topics covered by the National Law Review daily.

Visitors will always find the latest, up-to-date, most comprehensive coverage on the site. And, news and stories which affect the US, companies which are regulated in the industry, and multinational/international companies, are detailed regularly for NLR readers.

National Law Review Cannabis TwitterFor hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis X (formerly Twitter) feed, and sign up for complimentary e-news bulletins.

Recent Biotechnology, Food & Drug Administration FDA News

Title
Publication Date Organization Sort descending
Jul
8
2021
Transparency in Prescription Drug Pricing: Recent State and Federal Developments to Watch Greenberg Traurig, LLP
Aug
15
2013
China's Patent Re-Examination Board Says Pharmaceutical Salts Not Patentable Over Pure Compounds Greenberg Traurig, LLP
Nov
7
2013
New York City Proposes Expansion of Actions Exempt from City Environmental Quality Review (CEQR) Greenberg Traurig, LLP
Jun
6
2022
New California Bill Would Prohibit Employers From Acting Against Workers for Off-Work Cannabis Use Greenberg Traurig, LLP
May
22
2019
Roll Up, Roll Up: ‘Cannabis Inc.’ Is Open for Business, but UK Investors Must Wait Their Turn Greenberg Traurig, LLP
Dec
13
2014
FDA Issues Two Final Rules to Help Consumers Keep Track of Calories Greenberg Traurig, LLP
Jul
12
2022
China on the Move: Proposed Pharmaceutical Regulations Would Comprehensively Reform Regulatory Landscape Greenberg Traurig, LLP
Oct
28
2019
FDA Toughens Enforcement of Homeopathic Products Greenberg Traurig, LLP
Jul
10
2023
Assessing the 2023 Congressional Agenda Greenberg Traurig, LLP
Feb
6
2024
5 Trends to Watch: 2024 Class Actions Greenberg Traurig, LLP
Mar
11
2024
Competition Currents | March 2024 Greenberg Traurig, LLP
Mar
31
2021
Tax Issues and the New York Marijuana Regulation and Taxation Act Greenberg Traurig, LLP
Jan
4
2013
Fiscal Cliffhanger: Congress Passes Federal Tax & Health Care Legislation for 2013 Greenberg Traurig, LLP
Jun
20
2013
Surprise – U.S. Environmental Protection Agency (EPA) Misses Another Deadline for Issuing Draft Stormwater Regulations Greenberg Traurig, LLP
Jul
17
2013
China Life Science Laws and Regulations Update Greenberg Traurig, LLP
Sep
17
2013
Does Environmental Enforcement Against Individuals Make Sense? Greenberg Traurig, LLP
Sep
24
2018
It’s the Law: Don’t Sell Your Homebrew! Greenberg Traurig, LLP
Dec
12
2013
Air Regulation Update - Part I Re: Clean Air Act Greenberg Traurig, LLP
Dec
14
2014
Ebola: U.S. Provider Protocol and National Response Update Greenberg Traurig, LLP
Apr
3
2015
CMS Offers a New Accountable Care Organization Model Greenberg Traurig, LLP
Jul
22
2019
U.S. Supreme Court Broadens FOIA Exemption 4 for ‘Confidential’ Materials Greenberg Traurig, LLP
Feb
13
2020
First Circuit Class Action Litigation | Winter 2019/2020 Greenberg Traurig, LLP
Nov
20
2020
Florida Department of Health Issues 5 Notices of Emergency Rules Related to Medical Marijuana Treatment Centers Greenberg Traurig, LLP
Apr
4
2024
FDA Reminds Stakeholders of Animal Drug ‘Approved by FDA’ Labeling Requirements Greenberg Traurig, LLP
Sep
20
2012
STEM Jobs Act May Be On the Horizon Greenberg Traurig, LLP
Oct
29
2013
Environmental Protection Agency (EPA) Promulgates Toxic Substances Control Act (TSCA) Significant New Use Rule For Perfluorinated Chemicals – And Limits Its Applicability To “Articles” Greenberg Traurig, LLP
Nov
3
2013
Climate Change Adaptation Update: Executive Order and Draft Environmental Protection Agency (EPA) Implementation Plans Greenberg Traurig, LLP
Nov
11
2013
New Hart-Scott-Rodino (HSR) Rules Will Require More Filings for Pharmaceutical Patent Transfers: Increased Review Raises Importance of Valuation Greenberg Traurig, LLP
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins